Aharon Aharonov
- Molecular Biology
- Neurology top 5%
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cell Biology
- Co-authors
- Sara FuchsHarvey R. HerschmanRebecca M. PrussOded AbramskyIsrael SilmanRebeca Tarrab‐HazdaiR Tarrab-HazdaiColin Fox
- Topics
- Myasthenia Gravis and Thymoma (9 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)Cancer Treatment and Pharmacology (3 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Aharon Aharonov
21 papers receiving 966 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 528
- Neurology 431
- Oncology 238
- Radiology, Nuclear Medicine and Imaging 231
- Cell Biology 92
Countries citing papers authored by Aharon Aharonov
This map shows the geographic impact of Aharon Aharonov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aharon Aharonov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aharon Aharonov more than expected).
Fields of papers citing papers by Aharon Aharonov
This network shows the impact of papers produced by Aharon Aharonov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aharon Aharonov. The network helps show where Aharon Aharonov may publish in the future.
Co-authorship network of co-authors of Aharon Aharonov
This figure shows the co-authorship network connecting the top 25 collaborators of Aharon Aharonov. A scholar is included among the top collaborators of Aharon Aharonov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aharon Aharonov. Aharon Aharonov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Epidermal Growth Factor | 1 |
| 2 | 300 | |
| 3 | 23 | |
| 4 | 13 | |
| 5 | 10 | |
| 6 | 114 | |
| 7 | 174 | |
| 8 | 22 | |
| 9 | 40 | |
| 10 | [Myasthenia gravis and acetylcholine receptor]. | 5 |
| 11 | 16 | |
| 12 | 111 | |
| 13 | Proceedings: Animal model for myasthenia gravis: acetylcholine receptor-induced myasthenia in rabbits, guinea pigs and monkeys. | 5 |
| 14 | 45 | |
| 15 | Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. | 83 |
| 16 | 31 | |
| 17 | 89 | |
| 18 | 14 | |
| 19 | 7 | |
| 20 | 7 |
About Aharon Aharonov
Aharon Aharonov is a scholar working on Neurology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Neurology (431 citations), Radiology, Nuclear Medicine and Imaging (231 citations) and Oncology (238 citations). Aharon Aharonov has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Sara Fuchs, Harvey R. Herschman, Rebecca M. Pruss, Oded Abramsky, Israel Silman, Rebeca Tarrab‐Hazdai, R Tarrab-Hazdai, Colin Fox, Tokichi Miyakawa and Cynthia Webb. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.